PHIO PHARMACEUTICALS CORP (PHIO) Stock Balance Sheet
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.28M | 5.38M | 8.49M | 11.78M | 24.06M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 158.00K | 354.00K | 832.00K | 670.00K | 670.00K | |||
| Total Current Assets | 13.44M | 5.74M | 9.32M | 12.45M | 24.73M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.00K | 2.00K | 39.00K | 340.00K | 420.00K | |||
| Other Non-Current Assets | N/A | 0.00 | 3.00K | 20.00K | 30.00K | |||
| Total Non-Current Assets | 4.00K | 2.00K | 42.00K | 360.00K | 440.00K | |||
| TOTAL ASSETS | 13.44M | 5.74M | 9.36M | 12.81M | 25.17M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 843.00K | 762.00K | 977.00K | 1.16M | 2.79M | |||
| Accounts Payable | 427.00K | 253.00K | 657.00K | 780.00K | 280.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.27M | 1.01M | 1.63M | 1.94M | 3.07M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 30.00K | 170.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 30.00K | 170.00K | |||
| TOTAL LIABILITIES | 1.27M | 1.01M | 1.63M | 1.97M | 3.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -148.13M | -146.36M | -139.21M | -128.38M | -116.90M | |||
| Additional Paid In Capital | 160.29M | 151.08M | 146.94M | 139.22M | 138.83M | |||
| Common Shares | 0.00 | 200.00 | 400.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | -200.00 | -400.00 | N/A | N/A | |||
| Shares Outstanding | 4.78M | 1.73M | 416.40K | 1.14M | 1.13M | |||
| Tangible Book Value per Share | 2.55 | 2.72 | 18.57 | 9.51 | 19.41 | |||
| Total Shareholders' Equity | 12.17M | 4.72M | 7.73M | 10.84M | 21.93M | |||
| TOTAL LIABILITIES AND EQUITY | 13.44M | 5.74M | 9.36M | 12.81M | 25.17M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.58 | 5.65 | 5.71 | 6.42 | 8.06 | |||
| Return On Assets (ROA) | -50.36% | -124.61% | -117.47% | -89.62% | -52.80% | |||
| Return On Equity (ROE) | -55.62% | -151.39% | -142.30% | -105.90% | -60.60% | |||
All data in USD , ROIC based on taxRate of 0.21